These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18719053)

  • 21. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women.
    Birzniece V; Magnusson NE; Ho KK; Frystyk J
    Eur J Endocrinol; 2014 Mar; 170(3):375-83. PubMed ID: 24347426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status.
    Favoni RE; de Cupis A; Perrotta A; Sforzini S; Amoroso D; Pensa F; Miglietta L
    J Cancer Res Clin Oncol; 1995; 121(11):674-82. PubMed ID: 7593132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
    Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
    Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men.
    Yeap BB; Chubb SA; McCaul KA; Flicker L; Ho KK; Golledge J; Hankey GJ; Norman PE
    Eur J Endocrinol; 2012 Feb; 166(2):191-7. PubMed ID: 22113073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated insulin-like growth factor 2 expression may contribute to the hypermuscular phenotype of myostatin null mice.
    Clark DL; Clark DI; Hogan EK; Kroscher KA; Dilger AC
    Growth Horm IGF Res; 2015 Oct; 25(5):207-18. PubMed ID: 26198127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells.
    Pacher M; Seewald MJ; Mikula M; Oehler S; Mogg M; Vinatzer U; Eger A; Schweifer N; Varecka R; Sommergruber W; Mikulits W; Schreiber M
    Carcinogenesis; 2007 Jan; 28(1):49-59. PubMed ID: 16774935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis.
    Shapiro MR; Wasserfall CH; McGrail SM; Posgai AL; Bacher R; Muir A; Haller MJ; Schatz DA; Wesley JD; von Herrath M; Hagopian WA; Speake C; Atkinson MA; Brusko TM
    Diabetes; 2020 Mar; 69(3):413-423. PubMed ID: 31826866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes.
    Ukkola O; Sun G; Bouchard C
    Diabetologia; 2001 Dec; 44(12):2231-6. PubMed ID: 11793026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition.
    Belobrajdic DP; Frystyk J; Jeyaratnaganthan N; Espelund U; Flyvbjerg A; Clifton PM; Noakes M
    Eur J Endocrinol; 2010 Jun; 162(6):1075-82. PubMed ID: 20212016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance.
    Minchenko DO; Tsymbal DO; Davydov VV; Minchenko OH
    Endocr Regul; 2019 Jan; 53(1):34-45. PubMed ID: 31517621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.